首页> 外文OA文献 >382 Comparison of the efficacy of reiki versus sport as supportive care during neoadjuvant chemotherapy of early breast cancer: sub analysis of the randomized controlled reassure (Reiki as supportive treatment during chemotherapy of breast cancer) study

【2h】

382 Comparison of the efficacy of reiki versus sport as supportive care during neoadjuvant chemotherapy of early breast cancer: sub analysis of the randomized controlled reassure (Reiki as supportive treatment during chemotherapy of breast cancer) study

机译：382雷基斯与运动的疗效比较了早期乳腺癌新辅助化疗期间的支持性护理：随机控制放心的子分析（Reiki作为乳腺癌化疗过程中的支持性治疗）研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lena Zander; Lisa Haunreiter; Sophie Katzendobler; Rosemarie Schmidt; Rudolf Napieralski; Isabella Petri; Anne Andrulat; Katrin Münch; Claus Hanusch; Michael Braun; Marion Kiechle; Johannes Ettl;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial [J] . Blackwell Kimberly, Donskih Roman, Jones C. Michael, The oncologist . 2016,第7期

机译：拟议的生物仿制药LA-EP2006与参考培格非司亭预防早期乳腺癌接受骨髓抑制辅助或新辅助化疗的中性粒细胞减少症的比较：培格非司亭随机肿瘤治疗（支持治疗）以评估比较治疗（PROTECT-2），a第三阶段，随机双盲试验
2. A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial [J] . Kimberly Blackwell, Roman Donskih, C. Michael Jones, The oncologist . 2016,第7期

机译：拟议的生物仿制药LA-EP2006与参考培格非司亭用于预防早期接受骨髓抑制或新辅助化疗的乳腺癌中性粒细胞减少症的比较：培格非司亭随机肿瘤治疗（支持治疗）以评估比较治疗（PROTECT-2），a第三阶段，随机双盲试验
3. Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non-Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy [J] . Goldman Jonathan W., Shi Peipei, Reck Martin, Clinical lung cancer . 2016,第1期

机译：JUNIPER研究的治疗原理和研究设计：接受最佳支持治疗的Abemaciclib与依洛罗替尼进行最佳支持治疗的IV期随机临床试验，该研究针对IV级非小细胞肺癌，可检出KRAS突变的患者，其铂类药物已进展基于化学疗法
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. Supportive Care for Patients with Breast Cancer by Using an Interactive App During Neoadjuvant Chemotherapy: A Randomized Controlled Trial [D] . Fjell, Maria. 2021

机译：通过在Neoadjuvant化疗期间使用互动性应用的乳腺癌患者的支持性护理：随机对照试验
6. A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2) a Phase III Randomized Double-Blind Trial [O] . Kimberly Blackwell, Roman Donskih, C. Michael Jones, 2016

机译：拟议的生物仿制药LA-EP2006与参考培格非司亭预防早期乳腺癌接受骨髓抑制辅助或新辅助化疗的中性粒细胞减少症的比较：培格非司亭随机肿瘤治疗（支持治疗）以评估比较治疗（PROTECT-2）a第三阶段随机双盲试验
7. Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy [O] . Goldman Jonathan W., Shi Peipei, Reck Martin, 2016

机译：JUNIPER研究的治疗依据和研究设计：接受最佳支持治疗的Abemaciclib与依洛罗替尼进行最佳支持治疗的IV期随机研究，针对IV期非小细胞肺癌，可检出KRAS突变的患者，其铂类疾病已进展基于化学疗法

382 Comparison of the efficacy of reiki versus sport as supportive care during neoadjuvant chemotherapy of early breast cancer: sub analysis of the randomized controlled reassure (Reiki as supportive treatment during chemotherapy of breast cancer) study

著录项

引文网络

相似文献

相关主题

期刊订阅